Loading…
Loading…
OAKLAND, Calif., Aug. 21, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB: LOGC) (“ContextLogic,” the “Company,” “we” or “our”) today published a Q&A document to its website following the release of its second quarter 2026 financial results.
OAKLAND, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB: LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the quarter and six months ended June 30, 2026.
ContextLogic Holdings Inc. (LOGC) M&A Call Prepared Remarks Transcript
COVINGTON, La.--(BUSINESS WIRE)--Gaylord Chemical Company, L.L.C. (“gChem”), a global leader in non-toxic ingredients used in high-growth applications, today announced that ContextLogic Holdings Inc. (OTCQB: “LOGC”) and its subsidiaries (“ContextLogic”) have entered into a definitive agreement to acquire gChem from investment funds managed by EagleTree Capital (“EagleTree”) and their co-investors (the “Transaction”).
gChem will become ContextLogic's second operating business, following the acquisition of US Salt in February 2026 gChem is a sixty-four-year-old, vertically-integrated specialty chemicals company whose products serve highly specialized niches across diverse end markets, with decades-long customer relationships built on tailored, high-quality solutions ContextLogic shareholders will have the opportunity to commit additional capital in the Transaction via a rights offering, which has been fully backstopped at $9 per unit Transaction is expected to be materially accretive to free cash flow per unit OAKLAND, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB: LOGC) ("ContextLogic") today announced that ContextLogic Holdings, LLC and its newly formed subsidiary GCH Buyer, Inc. have entered into a definitive agreement to acquire the holding company of Gaylord Chemical, L.L.C.
LogicBio Therapeutics (OTCMKTS:LOGC - Get Free Report) is anticipated to post its Q2 2026 resultson Thursday, August 6th. Analysts expect LogicBio Therapeutics to post earnings of ($0.0414) per share and revenue of $22.4760 million for the quarter. Interested persons may review the information on the company's upcoming Q2 2026 earning results page for the latest
OAKLAND, Calif., July 13, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB: LOGC) (“ContextLogic,” the “Company,” “we” or “our”), a business ownership platform focused on acquiring and building a portfolio of high-quality, long-duration businesses, today announced that it has appointed Seth Siegel as a Senior Advisor.
OAKLAND, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings, Inc. (OTCQB: LOGC) (“ContextLogic,” the “Company,” “we” or “our”) announced the appointment of Scott Stewart as its Chief Financial Officer and Chief Operating Officer, effective June 1, 2026.